NP / PA
WT Medical Associates
WT Medical Associates was paid $4.96M by Medicaid between Jun 2018 and Dec 2024, across 148 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoWT MEDICAL ASSOCIATES
DYERSBURG, TN 38024
DYERSBURG, TN 38024
33aNPI1295223279assigned 04/25/2018
33bProvider typePrimary Care Nurse Practitioner
28Total paid$4.96M
24GClaims370,053
24DCodes billed148
24AFirst – last monthJun 2018 – Dec 2024
Compared with peers
Next to other Primary Care Nurse Practitioner providers in Tennessee
Rank by total paid#1 of 31
Median peer was paid$35K
This provider vs. median140×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,121 | $61K | |
| 2019 | 10,842 | $160K | |
| 2020 | 13,272 | $134K | |
| 2021 | 75,944 | $796K | |
| 2022 | 74,665 | $1.09M | |
| 2023 | 88,576 | $1.42M | |
| 2024incomplete | 100,633 | $1.30M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 38,832 | 30,482 | $1.35M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 42,764 | 34,721 | $1.30M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6.8% | 4,651 | 4,028 | $340K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.9% | 6,843 | 5,821 | $293K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.8% | 2,153 | 1,800 | $137K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.7% | 2,769 | 2,335 | $136K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.5% | 4,172 | 3,581 | $122K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.4% | 1,605 | 1,281 | $117K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.3% | 1,284 | 1,176 | $112K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.1% | 1,337 | 1,067 | $103K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.8% | 4,402 | 1,664 | $89K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 7,916 | 5,481 | $84K |
136 more codes
| 76819 | Fetal biophysical profile; without non-stress testing | 1.6% | 1,539 | $81K |
| 52000 | 1.5% | 881 | $73K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.0% | 947 | $50K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 518 | $44K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 504 | $33K |
| 76820 | <1% | 818 | $32K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 317 | $25K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,386 | $24K |
| 76801 | <1% | 365 | $23K | |
| 59025 | Fetal non-stress test | <1% | 859 | $22K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,835 | $20K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,931 | $18K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 262 | $18K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 378 | $18K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 17 | $17K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,484 | $13K |
| 81025 | <1% | 2,665 | $13K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 141 | $13K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,945 | $12K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 776 | $11K |
| 99383 | <1% | 127 | $11K | |
| 51798 | <1% | 1,761 | $9K | |
| 99381 | <1% | 100 | $9K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 318 | $9K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 830 | $9K |
| 51729 | <1% | 63 | $9K | |
| 90715 | <1% | 187 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,645 | $8K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 246 | $8K |
| 43235 | <1% | 140 | $7K | |
| 1160F | <1% | 17,128 | $7K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 62 | $7K |
| 1159F | <1% | 18,107 | $6K | |
| 81003 | <1% | 4,890 | $6K | |
| 87634 | <1% | 136 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 670 | $6K |
| 0500F | <1% | 428 | $5K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 143 | $5K |
| 3008F | <1% | 78,869 | $5K | |
| 81002 | <1% | 3,265 | $5K | |
| 99459 | <1% | 329 | $5K | |
| 51797 | <1% | 63 | $4K | |
| 76818 | <1% | 75 | $4K | |
| 97597 | <1% | 213 | $4K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 718 | $4K |
| 90686 | <1% | 586 | $4K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 43 | $3K |
| 96127 | <1% | 711 | $3K | |
| 3078F | <1% | 13,394 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 41 | $3K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 28 | $2K |
| 3077F | <1% | 5,229 | $2K | |
| 99460 | <1% | 48 | $2K | |
| 3074F | <1% | 11,762 | $2K | |
| 0503F | <1% | 523 | $2K | |
| 51784 | <1% | 63 | $2K | |
| 87807 | <1% | 163 | $2K | |
| 99382 | <1% | 14 | $2K | |
| 52204 | <1% | 52 | $1K | |
| 3079F | <1% | 4,057 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,021 | $1K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 13 | $1K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 27 | $1K |
| 87210 | <1% | 262 | $903.11 | |
| 90474 | <1% | 108 | $886.19 | |
| 92551 | <1% | 121 | $879.89 | |
| 51741 | <1% | 63 | $871.38 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 848 | $862.19 |
| 99441 | <1% | 42 | $858.42 | |
| 3075F | <1% | 2,152 | $795.74 | |
| 99173 | <1% | 135 | $757.85 | |
| 3080F | <1% | 1,422 | $720.67 | |
| 59430 | <1% | 14 | $678.04 | |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | <1% | 13 | $626.51 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 980 | $592.40 |
| 96380 | <1% | 68 | $527.04 | |
| 91200 | <1% | 61 | $480.45 | |
| 99490 | Ccm add 20min | <1% | 260 | $457.07 |
| 99305 | <1% | 65 | $440.99 | |
| 76770 | <1% | 34 | $420.90 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 927 | $409.36 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 47 | $381.43 |
| 90656 | <1% | 84 | $326.19 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 72 | $305.55 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 122 | $277.46 |
| 90697 | <1% | 615 | $242.18 | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 19 | $236.07 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 298 | $228.15 |
| 90461 | <1% | 4,945 | $204.83 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 164 | $203.11 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 22 | $195.14 |
| 90734 | <1% | 58 | $181.79 | |
| 94010 | <1% | 55 | $177.72 | |
| 93000 | <1% | 13 | $105.57 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 16 | $88.76 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 17 | $80.73 |
| 90662 | <1% | 24 | $65.26 | |
| 90687 | <1% | 68 | $11.34 | |
| G0008 | Administration of influenza virus vaccine | <1% | 136 | $1.62 |
| 1036F | <1% | 3,703 | $0.02 | |
| 3061F | 0% | 24,631 | $0.00 | |
| 4010F | 0% | 3,118 | $0.00 | |
| 90680 | 0% | 577 | $0.00 | |
| 90381 | 0% | 43 | $0.00 | |
| 3044F | 0% | 1,378 | $0.00 | |
| 3052F | 0% | 393 | $0.00 | |
| 90698 | 0% | 197 | $0.00 | |
| 0501F | 0% | 31 | $0.00 | |
| 90651 | 0% | 118 | $0.00 | |
| 3351F | 0% | 85 | $0.00 | |
| 99024 | 0% | 12 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 36 | $0.00 |
| 90674 | 0% | 64 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 12 | $0.00 |
| 1101F | 0% | 13 | $0.00 | |
| 90716 | 0% | 65 | $0.00 | |
| 3048F | 0% | 52 | $0.00 | |
| 1170F | 0% | 13 | $0.00 | |
| 90696 | 0% | 16 | $0.00 | |
| 3046F | 0% | 1,186 | $0.00 | |
| 90681 | 0% | 103 | $0.00 | |
| 0502F | 0% | 7,285 | $0.00 | |
| 90670 | 0% | 581 | $0.00 | |
| 90633 | 0% | 655 | $0.00 | |
| 90671 | 0% | 719 | $0.00 | |
| 90648 | 0% | 86 | $0.00 | |
| 90700 | 0% | 84 | $0.00 | |
| 3051F | 0% | 511 | $0.00 | |
| 90380 | 0% | 13 | $0.00 | |
| 99497 | 0% | 20 | $0.00 | |
| 90710 | 0% | 126 | $0.00 | |
| 3725F | 0% | 76 | $0.00 | |
| 1090F | 0% | 13 | $0.00 | |
| 90707 | 0% | 66 | $0.00 | |
| 99499 | 0% | 23 | $0.00 | |
| 3045F | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTEAGUE, BARTLEY (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| West Tennessee Medical Group INC | Jackson, TN | $8.19M |
| WT University Medical Associates INC | Jackson, TN | $7.49M |
| West Tennessee Healthcare Hospitalists INC | Jackson, TN | $4.30M |
| WT Medical Associates | Paris, TN | $2.48M |
| Jackson Madison County General Hospital | Jackson, TN | $1.51M |
| Martin Health | Martin, TN | $762K |
| Therapy & Learning Center INC | Jackson, TN | $83K |
| West Tennessee Healthcare Henry County | Paris, TN | $2K |
| WT Regional Medical Associates | Caruthersville, MO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.